Vaccine nanoparticles displaying recombinant Ebola virus glycoprotein for induction of potent antibody and polyfunctional T cell responses.

The recent outbreaks of Ebolavirus (EBOV) in West Africa underscore the urgent need to develop an effective EBOV vaccine. Here, we report the development of synthetic nanoparticles as a safe and highly immunogenic platform for vaccination against EBOV. We show that a large recombinant EBOV antigen (...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Nanomedicine
Auteurs principaux: Bazzill, Joseph D., Stronsky, Sabrina M., Kalinyak, Laura C., Ochyl, Lukasz J., Steffens, Jesse T., van Tongeren, Sean A., Cooper, Christopher L., Moon, James J.
Format: Artigo
Langue:Inglês
Publié: 2018
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6531357/
https://ncbi.nlm.nih.gov/pubmed/30471480
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nano.2018.11.005
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires